The FDA label includes a boxed warning about the risk of potential heart failure, fetal harm, and lung toxicity.
Pertuzumab/trastuzumab/hyaluronidase
Trastuzumab/hyaluronidase
Daratumumab/hyaluronidase
Bortezomib/dexamethasone
Loncastuximab tesirine
Decitabine/cedazuridine
Trastuzumab emtansine
Trifluridine/tipiracil